Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930072 · ClinicalTrials.gov registry record · Phase 2
Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
A Phase 2 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00930072 is a Phase 2 study that was terminated before completion, run by University of Washington. The registered enrollment target is 7 participants.
The verdict
NCT00930072, a Phase 2 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
To evaluate the feasibility of performing a cervical sympathetic block in patients with severe cerebral vasospasm involving the anterior cerebral circulation following aneurysmal SAH.
Interventions
- DRUG Cervical Sympathetic Block (bupivicaine, clonidine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00930072
The ClinicalTrials.gov registry entry for NCT00930072 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cervical Sympathetic Block (bupivicaine, clonidine) is the first listed.
NCT00930072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00930072 about?
NCT00930072 is a clinical study titled "Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage". To evaluate the feasibility of performing a cervical sympathetic block in patients with severe cerebral vasospasm involving the anterior cerebral circulation following aneurysmal SAH.
What is the current status of trial NCT00930072?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2009-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00930072?
The interventions under investigation include: Cervical Sympathetic Block (bupivicaine, clonidine) (DRUG).
Who is sponsoring clinical trial NCT00930072?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.